Literature DB >> 8561157

Prospective study of beverage use and the risk of kidney stones.

G C Curhan1, W C Willett, E B Rimm, D Spiegelman, M J Stampfer.   

Abstract

Patients with kidney stones are routinely advised to increase their fluid intake to decrease the risk of stone recurrence. However, there has been no detailed examination to determine whether the effect on recurrence varies by the type of beverage consumed. The authors conducted a prospective study of the relation between the intake of 21 different beverages and the risk of symptomatic kidney stones in a cohort of 45,289 men, 40-75 years of age, who had no history of kidney stones. Beverage use and other dietary information was measured by means of a semiquantitative food frequency questionnaire in 1986. During 6 years of follow-up (242,100 person-years), 753 incident cases of kidney stones were documented. After adjusting simultaneously for age, dietary intake of calcium, animal protein and potassium, thiazide use, geographic region, profession, and total fluid intake, consumption of specific beverages significantly added to the prediction of kidney stone risk (p < 0.001). After mutually adjusting for the intake of other beverages, the risk of stone formation decreased by the following amount for each 240-ml (8-oz) serving consumed daily: caffeinated coffee, 10% (95% confidence interval 4-15%); decaffeinated coffee, 10% (3-16%); tea, 14% (5-22%); beer, 21% (12-30%); and wine, 39% (10-58%). For each 240-ml serving consumed daily, the risk of stone formation increased by 35% (4-75%) for apple juice and 37% (1-85%) for grapefruit juice. The authors conclude that beverage type may have an effect on stone formation that involves more than additional fluid intake alone.

Entities:  

Mesh:

Year:  1996        PMID: 8561157     DOI: 10.1093/oxfordjournals.aje.a008734

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  66 in total

1.  Inhibition of oxalate nephrolithiasis with Ammi visnaga (AI-Khillah).

Authors:  Z A Khan; A M Assiri; H M Al-Afghani; T M Maghrabi
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

Review 2.  Current aspects of epidemiology and nutrition in urinary stone disease.

Authors:  A Hesse; R Siener
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

Review 3.  [Prevention of nephrolithiasis. Established strategies and new concepts].

Authors:  M Straub; R E Hautmann
Journal:  Urologe A       Date:  2004-04       Impact factor: 0.639

4.  Reexamination of total fluid intake and bladder cancer in the Health Professionals Follow-up Study Cohort.

Authors:  Jiachen Zhou; Scott Smith; Edward Giovannucci; Dominique S Michaud
Journal:  Am J Epidemiol       Date:  2012-02-21       Impact factor: 4.897

5.  Evaluation and medical management of the kidney stone patient.

Authors:  Ryan Paterson; Alfonso Fernandez; Hassan Razvi; Roger Sutton
Journal:  Can Urol Assoc J       Date:  2010-12       Impact factor: 1.862

Review 6.  Can the manipulation of urinary pH by beverages assist with the prevention of stone recurrence?

Authors:  Roswitha Siener
Journal:  Urolithiasis       Date:  2015-11-27       Impact factor: 3.436

Review 7.  The role of fluid intake in the prevention of kidney stone disease: A systematic review over the last two decades.

Authors:  Kithmini Nadeeshani Gamage; Enakshee Jamnadass; Sadaf Karim Sulaiman; Amelia Pietropaolo; Omar Aboumarzouk; Bhaskar K Somani
Journal:  Turk J Urol       Date:  2020-06-05

Review 8.  Caffeine in Kidney Stone Disease: Risk or Benefit?

Authors:  Paleerath Peerapen; Visith Thongboonkerd
Journal:  Adv Nutr       Date:  2018-07-01       Impact factor: 8.701

9.  Pediatric primary urolithiasis: Symptoms, medical management and prevention strategies.

Authors:  Maria Goretti Moreira Guimarães Penido; Marcelo de Sousa Tavares
Journal:  World J Nephrol       Date:  2015-09-06

10.  Ecological Momentary Assessment of Factors Associated with Water Intake among Adolescents with Kidney Stone Disease.

Authors:  Gregory E Tasian; Michelle Ross; Lihai Song; Janet Audrain-McGovern; Douglas Wiebe; Steven G Warner; Brittney Henderson; Anisha Patel; Susan L Furth
Journal:  J Urol       Date:  2019-03       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.